We added the following clinical trials for triple-negative, HER2-positive, and other subtypes of metastatic (stage IV) breast cancer to  Metastatic Trial Search last month.

Stage IV Triple Negative Breast Cancer

• Trilaciclib and Sacituzumab Govitecan for Advanced Triple Negative Breast Cancer
• RAPA-201 Immunotherapy for Advanced Triple Negative Breast Cancer
• How the Gut Microbiome May Affect Immunotherapy in Stage I-IV Triple Negative Breast Cancer

Stage IV HER2-Positive Trials

• Tucatinib With Trastuzumab and Pertuzumab for Advanced HER2+ Breast Cancer (HER2CLIMB-05)

Stage IV HR Positive Trials

• Imprime PGG and Pembrolizumab For HR+, HER2- Metastatic Breast Cancer

Other Stage IV Trials

• SAR408701 for CEACAM5-Positive Metastatic Breast Cancer

Last Modified on January 12, 2022